A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with cancer of the eye that has spread to the liver

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000417-44

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To compare overall survival (OS) in patients with hepatic-dominant metastatic ocular melanoma treated with Melphalan/HDS versus best alternative care (BAC).


Critère d'inclusion

  • Hepatic-Dominant Ocular Melanoma

Liens